Subject Matter Index T

A, B, C, D, E, F, G, H, I, J, K, L, M, N, O, P, Q, R, S, T, U, V, W, X, Y, Z

Tables submitted on read-only optical disc or via the USPTO patent electronic filing system as ASCII text file— 608.05 ; 608.05(b) ; 2422.03 ; 2422.03(a)
Technical documents— 901.06(a)
Technical rejections— 2120
Technology Center Director ( See Director of Technology Center)
Telephone call, multiplicity rejection— 2173.05(n)
Telephone numbers— 1730
- Attorney— 408 ; 713.01 ; 714.01
- Examiner— 707.08
- General information— 1730
Telephoning of attorney to examiner— 408 ; 713.01
Term, Patent— 707.05 ; 2701
- Adjustment of— 2701 ; 2710 ; 2730 ; 2731 ; 2732 ; 2733 ; 2734 ; 2736
  - Determination of— 2733
  - Due care showing— 2734
  - Grounds for— 2730
  - Period of— 2731
  - Reductions to— 2732
  - Request for reconsideration or reinstatement— 2730 ; 2732 ; 2733 ; 2734
  - Third party papers— 2736
- Continued prosecution application— 2730 ; 2732
- Deposit of biological material— 2408
- Design— 1502.01 ; 1505
- Divisional— 201.06
- Extension under 35 U.S.C. 156
  - FDA regulatory review and— 2750 – 2766
    - Deadline— 2754.01 ; 2754.02
    - Duty of disclosure and— 2762 ; 2762.01
    - Petition for stay in processing— 2765
    - Interim extension— 2755.01 ; 2755.02
    - Reissue— 2766
    - Specific Products
      - Animal drugs— 2750 ; 2751 ; 2753 ; 2757 ; 2758
      - Antibiotic drugs— 2751 ; 2758
      - Color additives …— 2750 ; 2751 ; 2754.01 ; 2758
      - Food additives— 2750 ; 2751 ; 2753 ; 2754.01 ; 2758
      - Medical devices— 2750 ; 2751 ; 2753 ; 2758
      - Veterinary Biological Products— 2750 ; 2751 ; 2756 ; 2758
    - Third party papers— 2763
    - Withdrawal— 2761 ; 2764
- Foreign— 901.05
- Transitional practice— 706.07(g) ; 803.03
- Utility— 2710
Terminal disclaimer ( See also Disclaimer)— 1490
- Avoiding/obviating double patenting issues— 804.02 ; 806.04(i) ; 1490 ; 2146.03 ; 2146.03(a) ; 2158
- Certificate of correction and— 2701 ; 2720
- Common ownership or joint research agreement— 1490
- Continued Prosecution Application (CPA)— 1490
- Continuing applications— 1490
- Copending applications procedure— 1490
- Forms and form paragraphs— 1490
- Request for Continued Examination (RCE)— 1490
- Reissue— 1402 ; 1410.02 ; 1411 ; 1451 ; 1490
- Required for revival— 711.03(c)
- Signature in— 402.03 ; 403.01(a) ; 1490
- Situations where not applicable— 804.03
- Withdrawal of— 1490
Terminology in application— 608.01(g) ; 608.01(o) ; 1302.01 ; 2175
Termination of proceedings— 211.01(a) ; 211.01(b) ; 711.02(c)
- Ex parte reexamination— 2265 ; 2266.01 ; 2268 ; 2271 ; 2281 ; 2285 ; 2286.01 ; 2294
Trademark Search— 608.01(v) ; 1703
Test comments— 707.07(l)
Testamentary, Letters ( See also Administrator or executor)— 409.01(b)
Testimony, examiner— 1701.01
Tests, comparative ( See Affidavits, traversing rejections (37 CFR 1.132))
Third action cases— 707.02
Third party submissions/inquiries/correspondence in published applications— 1134 ; 1134.01
Time and Activity Report— 1704 ; 1705
Time for claiming benefit of earlier application— 211.03
Time for deciding Director initiated reexamination— 2211 ; 2239
Time for deciding reexamination request— 2241
Time for filing papers, right of priority— 214.01 ; 215.02 ; 215.03
Time for filing petitions— 1002
Time for requesting reexamination
- Ex parte— 2210 ; 2211
Time for reply ( See also Period for reply)— 702.01 ; 710
Time for reply to action in reexamination
- Ex parte— 2263
Time limit— 710.02 ; 710.02(c)
- For making suggested claims— 710.02(c)
- International preliminary examination report (IPER)— 1879.01
- International search report (ISR)— 1843.05
- Period for reply— 710
- Permanent ink copy— 714.07
- Prior art filing— 2204
- Reply to final rejection— 706.07(f)
- Restriction requirement— 811
- Rewrite claims following Board decision— 1214.06
- Shortened statutory period compared to— 710.02 ; 710.02(b) ; 710.02(d)
- Statutory period— 710.01 ; 710.01(a)
- Transfer of application— 909.01(d) ; 909.02(d)
- Two periods running— 710.04
Time period for owner’s statement— 2249
Time reporting— 2238
Time to pay maintenance fees— 2506
Timely submission of protest— 1901.04
Title conveyed by assignment— 300
Title documents, handling— 317
Title of invention— 606 ; 1893.03(e)(1)
- Design application— 1503.01 ; 1504.01(a)
  - Amendment of— 1503.01
  - Use of Trademarks in— 1512
- International application— 1821
- Plant patent application— 1610
- Reviewed at issue— 606.01 ; 1302.01
Title report— 320 ; 2287
Titles of USPTO Officials—
Title with signature— 602.08(b)
Trade secret material— 724 – 724.05
- Completeness of file wrapper— 724.01
- Materials submitted covered by 35 U.S.C. 122— 724.04(a)
- Method of submitting— 724.02
- Office treatment and handling— 724.04 ; 724.06
  - After publication— 724.04(a)
- Petition to expunge materials— 724.05
- Reexamination under 37 CFR 1.11(d)— 724.04(c)
- Reissue under 37 CFR 1.11(b)— 724.04(b)
- Types of— 724.03
Trade secret submission label— 724.02
Trademark and trade name— 608.01(v) ; 2173.05(u) ; 2175 ; I
- Design patent, relationship to— 1512
- Misuse in patent specification— 608.01(v)
Trademark Manual of Examining Procedure—
Trademarks, Partial list of— I
Transfer of application
- After amendment— 909.01(c)
- Allowable application— 1305
- Divisible inventions— 812
- Interference— 2304.01(b)
- New— 909.01(a) ; 909.02(a)
- Primary examiner’s authority— 909.02
- Procedure— 909.01(d) ; 909.02(a) ; 909.02(d)
- Secrecy order application— 130
Transfer of class or subclass of design patents— 903.05
Transfer of drawing— 608.02(i)
Transfer of reexamination
- Ex parte— 2237
Transfer of rights to patent or application— 509.02 ; 509.04(a) ; 509.04(b)
Transfer of specification prohibited— 608.01(t)
Transfer of U.S. design patent— 903.05
Transitional application ( See also Application)
- After final practice— 706.07(g)
- Generic claim allowable— 803.03(b)
- Linking claim allowable— 803.03(a)
- Patent term— 2701
- Restriction practice— 803.03
Transitional phrases— 2111.03
- “Characterized by”— 2111.03
- “Composed of”— 2111.03
- “Comprising”— 2111.03 ; 2173.05(h)
- “Consisting essentially of”— 2111.03
- “Consisting of”— 2111.03 ; 2173.05(h)
- “Containing”— 2111.03
Translation, foreign application or foreign priority document— 214 ; 215 ; 216
Translations index in STIC— 901.06(a)
Translators in the U.S. Patent and Trademark Office— 901.05(d) ; 901.06(a)
Transmission, certificate of ( See Certificate of mailing or transmission (37 CFR 1.8))
Transmittal Fee, PCT— 1827
Traverse, answer all matters— 707.07(f)
Traverse, division or species requirement— 818 ; 821.01 ; 821.02
Traverse, rejection of linking claim— 818.01(d)
Treaties
- Benelux Designs Convention ( See also Design application)— 213.01 ; 1504.10
- Budapest Treaty ( See also Biotechnology and Microorganisms)— 901.05(b) ; 2402 ; 2404.01 ; 2405 ; 2407.05 ; 2408 ; 2409 ; 2410.01 ; 2410.02 ; 2411.01
- European Community Design— 1504.10
- European Patent Convention— 901.05
- GATT— 2138.02
- Hague Agreement ( See also Design application)— 213.01 ; 1504.10 ; Chapter 2900
- Hague Convention— 409.01(b) ; 602.04(a)
- NAFTA— 201.04 ; 715 ; 715.07(c) ; 2132 ; 2138.02
- Paris Convention— 213 ; 1502.01
- Patent Cooperation Treaty (PCT)— 1502.01 ; 1800 ; AI ; T
- Patent Law— 702
- Strasbourg Agreement— 906
- UPOV Convention ( See also Plant patent)— 1612 ; 1613
- Uruguay Round Agreements Act (URAA)— 201.04 ; 715 ; 715.07(c) ; 804 ; 2701 ; 2720 ; 2730 ; 2132
Trial Proceedings, Duty to disclose— 2001 ; 2001.06(c)
TRIPS Agreement (Trade-Related Aspects of Intellectual Property)— 1801
Tubers— 1601
Twenty year term ( See Term, Patent)
Two month delay period in reissues— 1441
Two periods for reply running— 710.04
Type font— 608.01 ; 1504.01(a)

A, B, C, D, E, F, G, H, I, J, K, L, M, N, O, P, Q, R, S, T, U, V, W, X, Y, Z

This page is owned by Patents.

Last Modified: 10/30/2024 08:50:22